What were the main findings from the estrogen plus progestin and breast cancer analyses?
More women who took estrogen plus progestin (E+P) developed breast cancer than women taking placebo (inactive pills). The cancer cases found in women taking E+P had similar characteristics (looked the same under the microscope), but the tumors were larger and had spread more throughout the body than those in the placebo group.